浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Effects of active ingredients of traditional Chinese medicine in the prevention and treatment of senile macular degeneration and the research progress of its ocular new drug delivery preparations
- ZHONGGUO YAOFANG Vol. 35, Issue 19, Pages: 2432-2437(2024)
- 作者机构：
1.成都大学药学院，成都 610106
2.成都大学基础医学院，成都 610106
3.成都中医药大学药学院，成都 611137
4.成都大学食品与生物工程学院，成都 610106
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2024.19.19
CLC： R285;R943Published：15 October 2024，
Received：18 March 2024，
Revised：27 August 2024，
- 稿件说明：
移动端阅览
朱雅迪,李维,李淑瑶等.中药活性成分防治老年性黄斑变性的作用及其新型眼部递送制剂研究进展 Δ[J].中国药房,2024,35(19):2432-2437.
ZHU Yadi,LI Wei,LI Shuyao,et al.Effects of active ingredients of traditional Chinese medicine in the prevention and treatment of senile macular degeneration and the research progress of its ocular new drug delivery preparations[J].ZHONGGUO YAOFANG,2024,35(19):2432-2437.
朱雅迪,李维,李淑瑶等.中药活性成分防治老年性黄斑变性的作用及其新型眼部递送制剂研究进展 Δ[J].中国药房,2024,35(19):2432-2437. DOI： 10.6039/j.issn.1001-0408.2024.19.19.
ZHU Yadi,LI Wei,LI Shuyao,et al.Effects of active ingredients of traditional Chinese medicine in the prevention and treatment of senile macular degeneration and the research progress of its ocular new drug delivery preparations[J].ZHONGGUO YAOFANG,2024,35(19):2432-2437. DOI： 10.6039/j.issn.1001-0408.2024.19.19.
摘要
老年性黄斑变性（SMD）是一种造成老年人视力损伤的眼部黄斑区退行性疾病，发病率较高，是目前国内外眼科疾病治疗研究的重点和难点。本文对防治SMD的常用中药活性成分及其新型眼部递送制剂进行综述，结果显示，许多中药活性成分可通过抗氧化、抗衰老、抗凋亡、抗炎等多种途径抑制SMD的病情进展。但由于大多数中药活性成分具有溶解度低、化学性质不稳定以及难以克服眼部屏障等缺点，严重阻碍了其在治疗SMD中的临床应用。以脂质体、固体脂质纳米粒、微乳/纳米乳、原位凝胶等为代表的新型制剂在眼部药物递送方面具有良好的应用前景。
Abstract
enile macular degeneration（SMD） is a degenerative disease of the macular region of the eye that causes visual impairment in older people worldwide. It is the focus and difficulty of the treatment of ophthalmic diseases at home and abroad. This paper reviewed traditional Chinese medicine （TCM） active ingredients for the treatment and prevention of SMD， and its new ocular delivery preparations. Studies have shown that many active ingredients of TCM can inhibit the progression of SMD through various ways such as anti-oxidation， solid lipid nanoparticles， microemulsions/nanoemulsions， in-situ gel， etc. However， due to the low solubility， chemical instability and difficulty in overcoming the eye barrier of most TCM active ingredients， their clinical application in the treatment of SMD is seriously hindered. New preparations， such as liposomes， solid lipid nanoparticles， microemulsion/nanoemulsion， in situ gels， have good application prospects in ocular drug delivery.
关键词
老年性黄斑变性中药活性成分氧化应激炎症纳米制剂
Keywords
active ingredients of traditional Chinese medicineoxidative stressinflammationnano preparation
references
欧阳灵艺，邢怡桥. 抗VEGF药物在湿性年龄相关性黄斑变性中的应用进展[J]. 国际眼科杂志，2020，20（1）：74-78.
OUYANG L Y，XING Y Q. Current advance in the application of anti-vascular endothelial growth factor drugs in wet age-related macular degeneration[J]. Int Eye Sci，2020，20（1）：74-78.
李晓宇，梁丽娜，高云，等. 明睛颗粒联合雷珠单抗对湿性年龄相关性黄斑变性纤维血管膜纤维化相关蛋白表达的影响[J]. 天津中医药大学学报，2024，43（2）：130-137.
LI X Y，LIANG L N，GAO Y，et al. Mingjing granules combined with leizumab on vascular membrane fibrosis associated proteins in wet age-related macular degeneration[J]. J Tianjin Univ Tradit Chin Med，2024，43（2）：130-137.
WONG W L，SU X Y，LI X，et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040：a systematic review and meta-analysis[J]. Lancet Glob Health，2014，2（2）：e106-e116.
SREEKUMAR P G，REDDY S T，HINTON D R，et al. Mechanisms of RPE senescence and potential role of αB crystallin peptide as a senolytic agent in experimental SMD[J]. Exp Eye Res，2022，215：108918.
张敬法，张宇萌，孙晓东. 干性年龄相关性黄斑变性发病机制及治疗[J]. 眼科新进展，2022，42（3）：169-178.
ZHANG J F，ZHANG Y M，SUN X D. Pathogenesis and treatment of dry age-related macular degeneration[J]. Recent Adv Ophthalmol，2022，42（3）：169-178.
FLECKENSTEIN M，KEENAN TDL，GUYMER RH， et al. Age-related macular degeneration[J]. Nat Rev Dis Primers，2021，7（1）：31.
孟欢，金明. 年龄相关性黄斑变性的中医药研究进展[J]. 北京中医药，2020，39（8）：891-895.
MENG H，JIN M. Progress of traditional Chinese medicine research on age-related macular degeneration[J]. Beijing J Tradit Chin Med，2020，39（8）：891-895.
裴超，韩学杰，冯俊. 中医药治疗年龄相关性黄斑变性研究进展[J]. 世界中西医结合杂志，2020，15（8）：1561-1564.
PEI C，HAN X J，FENG J. Research progress in the treatment of age-related macular degeneration with traditional Chinese medicine[J]. World J Integr Tradit West Med，2020，15（8）：1561-1564.
于方海. 杞黄颗粒及枸杞多糖对RPE细胞自噬功能影响效果研究[D]. 天津：天津中医药大学，2023.
YU F H. Effects of Qihuang granules and Lycium barbarum polysaccharide on autophagy of RPE cells[D]. Tianjin：Tianjin University of Traditional Chinese Medicine，2023.
王龙龙，刘蓓蓓. 养血益睛汤治疗早期干性年龄相关性黄斑变性疗效观察[J]. 安徽中医药大学学报，2021，40（5）：24-27.
WANG L L，LIU B B. Clinical effect of Yangxue yijing decoction in treatment of early-stage dry age-related macular degeneration[J]. J Anhui Univ Chin Med，2021，40（5）：24-27.
张巧玲，王军敬，茹祥艳. 健脾滋肾复明汤治疗湿性老年性黄斑变性的疗效探析[J]. 深圳中西医结合杂志，2020，30（2）：46-48.
ZHANG Q L，WANG J J，RU X Y. Therapeutic effect of Jianpi zishen fuming decoction on wet age-related macular degeneration[J]. Shenzhen J Integr Tradit Chin West Med，2020，30（2）：46-48.
ZHU W，WU Y，MENG Y F，et al. Effect of curcumin on aging retinal pigment epithelial cells[J]. Drug Des Devel Ther，2015，9：5337-5344.
HYTTI M，PIIPPO N，SALMINEN A，et al. Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells[J]. Exp Eye Res，2015，132：208-215.
ZHU Q，LIU M X，HE Y X，et al. Quercetin protect cigarette smoke extracts induced inflammation and apoptosis in RPE cells[J]. Artif Cells Nanomed Biotechnol，2019，47（1）：2010-2015.
陈岚. 薯蓣皂苷元通过AKT/GSK-3β信号通路抑制内皮间质转化并减轻激光诱导小鼠的脉络膜新生血管形成[D]. 南京：南京中医药大学，2023.
CHEN L. Diosgenin inhibits endothelial mesenchymal transition and reduces laser-induced choroidal neovascularization in mice through AKT/GSK-3β signaling pathway[D]. Nanjing：Nanjing University of Chinese Medicine，2023.
SHEN Y，ZHUANG P，LIN B Q，et al. Effect of tetrame- thylpyrazine on RPE degeneration，choroidal blood flow and oxidative stress of RPE cells[J]. Int J Ophthalmol，2010，3（3）：205-210.
YANG J N，CHEN J M，LUO L，et al. Tetramethylpy- razine protected photoreceptor cells of rats by modulating nuclear translocation of NF-kappa B[J]. Acta Pharmacol Sin，2005，26（7）：887-892.
ZOU Y H，JIANG W，CHIOU G C Y. Effect of tetrame- thylpyrazine on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro[J]. Curr Eye Res，2007，32（1）：71-75.
KOZLOWSKI M R，BOND K E，MANESH M N，et al. Inhibition of senescence in RPE cells by astragaloside Ⅳ：implications for treating SMD[J]. Investig Ophthalmol Vis Sci，2015，56（7）：178.
SUN H J，JIN X M，XU J，et al. Baicalin alleviates age-related macular degeneration via miR-223/NLRP3-regulated pyroptosis[J]. Pharmacology，2020，105（1/2）：28-38.
DELMAS D，CORNEBISE C，COURTAUT F，et al. New highlights of resveratrol：a review of properties against ocular diseases[J]. Int J Mol Sci，2021，22（3）：1295.
金玫宏，崔俊，崔仁哲. 人参皂苷在年龄相关性黄斑变性中的作用研究进展[J]. 吉林医学，2022，43（7）：1961-1963.
JIN M H，CUI J，CUI R Z. Research progress on the role of ginsenoside in age-related macular degeneration[J]. Jilin Med J，2022，43（7）：1961-1963.
陈宁. 鱼明胶-高酯果胶-姜黄素复合可食膜制备及工厂设计[D]. 南昌：南昌大学，2022.
CHEN N. Preparation and factory design of fish gelatin-high ester pectin-curcumin composite edible film[D]. Nanchang：Nanchang University，2022.
曾慧慧. 基于槲皮素的水凝胶/纳米递送系统的设计及应用研究[D]. 长沙：中南大学，2022.
ZENG H H. Design and application of hydrogel/nanodelivery system based on quercetin[D]. Changsha：Central South University，2022.
彭后平，孙丽萍，李晓林，等. 眼表局部给药的屏障及克服屏障的方法研究进展[J]. 药学进展，2021，45（11）：835-847.
PENG H P，SUN L P，LI X L，et al. Progress of research on ocular barriers of topical drug delivery and strategies to overcome the barriers[J]. Prog Pharm Sci，2021，45（11）：835-847.
BONILLA L，ESPINA M，SEVERINO P，et al. Lipid nanoparticles for the posterior eye segment[J]. Pharmaceutics，2021，14（1）：90.
GU H，CHEN P，LIU X，et al. Trimethylated chitosan-coated flexible liposomes with resveratrol for topical drug delivery to reduce blue-light-induced retinal damage[J]. Int J Biol Macromol，2023，252：126480.
ASHRAF O，NASR M，NEBSEN M，et al. In vitro stabilization and in vivo improvement of ocular pharmacokine- tics of the multi-therapeutic agent baicalin：delineating the most suitable vesicular systems[J]. Int J Pharm，2018，539（1/2）：83-94.
LAI S S，WEI Y Y，WU Q W，et al. Liposomes for effective drug delivery to the ocular posterior chamber[J]. J Nanobiotechnology，2019，17（1）：64.
EID H M，ELKOMY M H，EL MENSHAWE S F，et al. Development，optimization，and in vitro/in vivo characte- rization of enhanced lipid nanoparticles for ocular delivery of ofloxacin：the influence of pegylation and chitosan coa- ting[J]. AAPS PharmSciTech，2019，20（5）：183.
LIU Z D，ZHANG X H，WU H Y，et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo[J]. Drug Dev Ind Pharm，2011，37（4）：475-481.
LI W，CHEN L，GU Z W，et al. Co-delivery of microRNA-150 and quercetin by lipid nanoparticles （LNPs） for the targeted treatment of age-related macular degeneration （AMD）[J]. J Control Release，2023，355：358-370.
陈文培. 柚皮素防治干性年龄相关性黄斑变性的作用及机制研究[D]. 广州：广州中医药大学，2019.
CHEN W P. Study on the effect and mechanism of naringin in preventing and treating dry age-related macular degeneration[D]. Guangzhou：Guangzhou University of Chinese Medicine，2019.
马钰. 眼用柚皮素微乳的制备及其抗小鼠角膜新生血管的研究[D]. 郑州：河南中医药大学，2022.
MA Y. Preparation of naringin microemulsion for eye and its anti-corneal neovascularization in mice[D]. Zhengzhou：Henan University of Chinese Medicine，2022.
SONG D L，SONG J T，WANG C G，et al. Berberine protects against light-induced photoreceptor degeneration in the mouse retina[J]. Exp Eye Res，2016，145：1-9.
李方琴. 盐酸小檗碱纳米乳的制备及对干性SMD模型小鼠的作用研究[D]. 南昌：江西中医药大学，2023.
LI F Q. Preparation of berberine hydrochloride nanoemulsion and its effect on dry SMD model mice[D]. Nanchang：Jiangxi University of Traditional Chinese Medicine，2023.
许凯. 黄芪甲苷纳米乳眼用凝胶对实验性大鼠干性年龄相关性黄斑变性的作用研究[D]. 北京：中国中医科学院，2018.
XU K. Effect of astragaloside Ⅳ nanoemulsion ophthalmic gel on experimental dry age-related macular degeneration in rats[D]. Beijing：China Academy of Chinese Medical Sciences，2018.
BHATTACHARJEE A，DAS P J，ADHIKARI P，et al. Novel drug delivery systems for ocular therapy：with special reference to liposomal ocular delivery[J]. Eur J Ophthalmol，2019，29（1）：113-126.
李秀敏，汤湛，王俏. 眼部给药系统的研究进展[J]. 中国现代应用药学，2021，38（18）：2296-2304.
LI X M，TANG Z，WANG Q. Research progress on ophthalmic drug delivery systems[J]. Chin J Mod Appl Pharm，2021，38（18）：2296-2304.
何朝星，王欣，高淑颖，等. 白藜芦醇眼用纳米乳-离子敏感型原位凝胶的制备与质量评价[J]. 中国药学杂志，2022，57（2）：124-131.
HE C X，WANG X，GAO S Y，et al. Preparation and qua- lity evaluation of resveratrol ophthalmic nanoemulsion-ion sensitive in situ gel[J]. Chin Pharm J，2022，57（2）：124-131.
LIU C Y，SU W T，JIANG X，et al. A sustainable retinal drug co-delivery for boosting therapeutic efficacy in wSMD：unveiling multifaceted evidence and synergistic mechanisms[J]. Adv Healthc Mater，2024，13（14）：e2303659.
0
Views
0
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.